Pharmaniaga posts improved Q3 and nine-month results, declares 0.32 sen dividend
Key business divisions continued to demonstrate resilience and steady progress, says managing director PETALING JAYA: Pharmaniaga Bhd recorded higher revenue and profitability for the third quarter and nine months ended Sept 30, 2026, reflecting continued progress in strengthening its profitability…
Pharmaniaga posted higher Q3 profit, with PAT rising to RM26.9 million, a threefold increase, while revenue grew 0.7% to RM1.01 billion, driven by insulin sales.
PAT jumped from RM7.5 million to RM26.9 million year‑on‑year
Revenue rose modestly 0.7% to RM1.01 billion
EBITDA increased 0.9% to RM33 million
Summarised automatically by AI from the original article by The Sun. AI can make mistakes, so check the original for details.
PETALING JAYA: Pharmaniaga Bhd recorded higher revenue and profitability for the third quarter and nine months ended Sept 30, 2026, reflecting continued progress in strengthening its profitability and financial position.
For the third quarter, profit after taxation and zakat (PAT) jumped more than threefold to RM26.9 million from RM7.5 million in the corresponding quarter of the previous financial year.
This improved profitability was achieved against a modest 0.7% increase in revenue to RM1.01 billion, primarily driven by higher insulin sales during the quarter.
Meanwhile, the group’s earnings before interest, taxes, depreciation and amortisation (Ebitda) rose 0.9% year-on-year to RM33 million.
Read the full story on The SunYou've read the opening, about 100 of 417 words. The full piece is published by The Sun.
AI summary South Korean police investigate the top scorer of a national tax accountant exam after he admitted using AI and a miniature camera to cheat, scoring 397.5/400 in the first round.
AI summary Prime Minister Anwar Ibrahim and Canadian PM Mark Carney discussed expanding trade in energy, digital economy, and tech at the ASEAN Summit.
